Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
Clinical Diabetes : a Publication of the American Diabetes Association|October 21, 2024
Erratum: Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages. Clinical Diabetes 2023;41:467-473Heather P Whitley, Jennifer M Trujillo, Joshua J NeumillerClinical Diabetes : a Publication of the American Diabetes Association|February 4, 2015
Efficacy and safety of saxagliptin as add-on therapy in type 2 diabetesJoshua J NeumillerDiabetes Spectrum : a Publication of the American Diabetes Association|February 17, 2025
Meeting People Where They Are: Improving Diabetes Care and Outcomes Through Education and CollaborationJoshua J NeumillerClinical Therapeutics|June 14, 2011
Clinical pharmacology of incretin therapies for type 2 diabetes mellitus: implications for treatmentJoshua J NeumillerThe Annals of Pharmacotherapy|February 10, 2012
Pharmacology, efficacy, and safety of linagliptin for the treatment of type 2 diabetes mellitusJoshua J NeumillerJournal of the American Pharmacists Association : Japha|October 6, 2009
Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitorsJoshua J NeumillerCardiovascular & Hematological Agents in Medicinal Chemistry|July 26, 2012
Incretin pharmacology: a review of the incretin effect and current incretin-based therapiesJoshua J NeumillerDrugs in Context|July 4, 2014
Empagliflozin: a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetesJoshua J NeumillerThe Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|April 5, 2011
Monetary value of a prescription assistance program service in a rural family medicine clinicHeather P WhitleyPageof 19